We are live on ! Find out more
SRGA

Surgalign Holdings, Inc. Common Stock

Delisted

SRGA was delisted on the 30th of June, 2023.

36 hedge funds and large institutions have $3.43M invested in Surgalign Holdings, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% less funds holding

Funds holding: 4036 (-4)

11% less capital invested

Capital invested by funds: $3.85M → $3.43M (-$421K)

50% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 8

57% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 7

Holders
36
Holders Change
-4
Holders Change %
-10%
% of All Funds
0.62%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
4
Reduced
8
Closed
7
Calls
$44K
Puts
Net Calls
+$44K
Net Calls Change
-$6K

SRGA Hedge Fund Activity: Q3 2022 in Review

36 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q3 2022, worth a combined $3.43M — down 11% from $3.85M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of SRGA and 3 opened new positions — a net loss of 4 holders — while 8 trimmed existing stakes and 4 added.

The largest buyer was Atria Wealth Solutions, adding an estimated $210K. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $239K sold.

  • 36 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q3 2022, down from 40 in Q2 2022.
  • Funds reported $3.43M of Surgalign Holdings, Inc. Common Stock stock for Q3 2022, down 11% quarter-over-quarter.
  • 3 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q3 2022 and 7 closed out, a net change of -4 holders.
  • The largest Surgalign Holdings, Inc. Common Stock buyer in Q3 2022 was Atria Wealth Solutions, an estimated $210K added.
  • The largest Surgalign Holdings, Inc. Common Stock seller in Q3 2022 was Alyeska Investment Group, an estimated $239K sold.

Based on aggregated 13F filings for Q3 2022.